INSERM, U866, Dijon, France.
Int J Biochem Cell Biol. 2012 Oct;44(10):1593-612. doi: 10.1016/j.biocel.2012.06.012. Epub 2012 Jun 29.
The members of the small heat shock protein (sHSP) family are molecular chaperones that play major roles in development, stress responses, and diseases, and have been envisioned as targets for therapy, particularly in cancer. The molecular mechanisms that regulate their transcription, in normal, stress, or pathological conditions, are characterized by extreme complexity and subtlety. Although historically linked to the heat shock transcription factors (HSFs), the stress-induced or developmental expression of the diverse members, including HSPB1/Hsp27/Hsp25, αA-crystallin/HSPB4, and αB-crystallin/HSPB5, relies on the combinatory effects of many transcription factors. Coupled with remarkably different cis-element architectures in the sHsp regulatory regions, they confer to each member its developmental expression or stress-inducibility. For example, multiple regulatory pathways coordinate the spatio-temporal expression of mouse αA-, αB-crystallin, and Hsp25 genes during lens development, through the action of master genes, like the large Maf family proteins and Pax6, but also HSF4. The inducibility of Hsp27 and αB-crystallin transcription by various stresses is exerted by HSF-dependent mechanisms, by which concomitant induction of Hsp27 and αB-crystallin expression is observed. In contrast, HSF-independent pathways can lead to αB-crystallin expression, but not to Hsp27 induction. Not surprisingly, deregulation of the expression of sHSP is associated with various pathologies, including cancer, neurodegenerative, or cardiac diseases. However, many questions remain to be addressed, and further elucidation of the developmental mechanisms of sHsp gene transcription might help to unravel the tissue- and stage-specific functions of this fascinating class of proteins, which might prove to be crucial for future therapeutic strategies. This article is part of a Directed Issue entitled: Small HSPs in physiology and pathology.
小分子热休克蛋白(sHSP)家族成员是分子伴侣,在发育、应激反应和疾病中发挥重要作用,被认为是治疗的靶点,特别是在癌症中。在正常、应激或病理条件下,调节它们转录的分子机制具有极端的复杂性和微妙性。尽管它们历史上与热休克转录因子(HSFs)有关,但包括 HSPB1/Hsp27/Hsp25、αA-晶体蛋白/HSPB4 和 αB-晶体蛋白/HSPB5 在内的多种成员的应激诱导或发育表达依赖于许多转录因子的组合效应。再加上 sHsp 调节区中明显不同的顺式元件结构,它们赋予每个成员其发育表达或应激诱导性。例如,多个调节途径通过主基因(如大 Maf 家族蛋白和 Pax6),但也通过 HSF4,协调小鼠 αA-、αB-晶体蛋白和 Hsp25 基因在晶状体发育过程中的时空表达。各种应激诱导 Hsp27 和 αB-晶体蛋白转录的诱导作用是通过 HSF 依赖的机制发挥的,同时观察到 Hsp27 和 αB-晶体蛋白表达的诱导。相比之下,HSF 非依赖性途径可导致 αB-晶体蛋白表达,但不能诱导 Hsp27 表达。毫不奇怪,sHSP 表达的失调与各种病理学有关,包括癌症、神经退行性或心脏疾病。然而,仍有许多问题需要解决,进一步阐明 sHSP 基因转录的发育机制可能有助于揭示这一类迷人蛋白质的组织和阶段特异性功能,这可能对未来的治疗策略至关重要。本文是一个题为“小分子热休克蛋白在生理和病理中的作用”的专刊的一部分。